東華大學圖書館 |

Perspectives on Participation in Dementia Prevention Clinical Trials.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Perspectives on Participation in Dementia Prevention Clinical Trials./
作者:	Akenine, Ulrika.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2021,
面頁冊數:	72 p.
附註:	Source: Dissertations Abstracts International, Volume: 82-11, Section: B.
Contained By:	Dissertations Abstracts International82-11B.
標題:	Gerontology. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28518255
ISBN:	9798728224402

Perspectives on Participation in Dementia Prevention Clinical Trials.
Akenine, Ulrika.

Perspectives on Participation in Dementia Prevention Clinical Trials. - Ann Arbor : ProQuest Dissertations & Theses, 2021 - 72 p.

Source: Dissertations Abstracts International, Volume: 82-11, Section: B.

Thesis (Ph.D.)--Karolinska Institutet (Sweden), 2021.

This item must not be sold to any third party vendors.

Dementia is an enormous global health challenge with a rapid increase in the number of people affected. There is an urgent need for research to find effective treatments and preventive strategies. Dementia prevention research is undergoing rapid development with novel approaches and techniques used. Both pharmacological and multimodal lifestyle randomized controlled trials (RCTs) have become longer, more complex, and target people earlier in the disease continuum. For the participants in clinical trials, this means new challenges.The overall aim of this thesis was to explore the experiences of participation in dementia prevention clinical trials among study participants, study partners, and specialized personnel/ staff. Furthermore, the aim was to further understand their attitudes and knowledge about dementia and related diagnoses. All studies used qualitative method. Data from different kind of RCTs was collected with questionnaires including open-ended questions, focus groups and individual interviews. Content analysis and Grounded theory were used.Study I Questionnaire with open-ended questions to 19 participants and 20 study partners in immunotherapy Alzheimer ́s disease (AD) phase I-II RCTs and group interview with eight staff members in the clinical trial unit were used. Staff members highlighted the high burden for the participants. The main motives for participation were a willingness to help research and the benefits of access to specialized care. The main disadvantages were that participating was time-consuming and perceived distress in connection to some investigations.Study II Focus group interviews were conducted within the Healthy Ageing Through Internet Counselling in the Elderly (HATICE) study with expert nurses (n=13) in cardiovascular disease (CVD) prevention in Finland and in the Netherlands. The purpose was to describe nurses' best experiences and practices with supporting CVD prevention and describe their suggestions on how to integrate their experiences into an online eHealth platform. Important aspects were to establish a relationship of trust, awareness and expectation management, and appropriate time and monitoring.Study III Focus groups interviews with older "at risk" adults (presence of CVD risk factors) in Finland, The Netherlands, and France were conducted as part of the HATICE study (n=44). The purpose was to explore attitudes of older adults at increased risk of CVD and dementia and engagement in an eHealth self-management prevention program as well as facilitators and barriers. The results were represented in three categories: access to reliable information about CVD and dementia, trust in the healthcare provider, and burden and stigma of dementia.Study IV Individual interviews with participants in multimodal dementia prevention MIND-ADMINI trial among persons with prodromal AD (n=8) were conducted. The participants' experience of participating in the trial is presented as a dynamic process. Previous knowledge, their motives, and the received information guide the participants' decision to take part in the trial. The trial was well tolerated and received even though the participants initially experienced high burden and difficulties managing information provided.Conclusions: Despite differences in the trials and target populations, the participants presented similar motives for participating in dementia prevention trials including altruistic, hope for personal benefits of the interventions, and access to specialized care. There are differences in the participants' preferences and need for support in a trial, between the participating countries, and along the disease continuum. To address this, a more person-centred approach in the conduction of the trials is suggested. This may improve participant ́s situation and the quality of RCTs which is important given the increasing complexity and new methods used in dementia prevention trials.

ISBN: 9798728224402Subjects--Topical Terms:

533633
Gerontology.
Subjects--Index Terms:

COVID-19

Perspectives on Participation in Dementia Prevention Clinical Trials.
LDR:05160nmm a2200385 4500 001 2283158
005 20211022115657.5
008 220723s2021 ||||||||||||||||| ||eng d
020 $a 9798728224402
035 $a (MiAaPQ)AAI28518255
035 $a (MiAaPQ)Karolinska_1061647539
035 $a AAI28518255
040 $a MiAaPQ $c MiAaPQ
100 1 $a Akenine, Ulrika. $3 3562083
245 1 0 $a Perspectives on Participation in Dementia Prevention Clinical Trials.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2021
300 $a 72 p.
500 $a Source: Dissertations Abstracts International, Volume: 82-11, Section: B.
500 $a Advisor: Kivipelto, Miia;Solomon, Alina;Fallahpour, Mandana.
502 $a Thesis (Ph.D.)--Karolinska Institutet (Sweden), 2021.
506 $a This item must not be sold to any third party vendors.
520 $a Dementia is an enormous global health challenge with a rapid increase in the number of people affected. There is an urgent need for research to find effective treatments and preventive strategies. Dementia prevention research is undergoing rapid development with novel approaches and techniques used. Both pharmacological and multimodal lifestyle randomized controlled trials (RCTs) have become longer, more complex, and target people earlier in the disease continuum. For the participants in clinical trials, this means new challenges.The overall aim of this thesis was to explore the experiences of participation in dementia prevention clinical trials among study participants, study partners, and specialized personnel/ staff. Furthermore, the aim was to further understand their attitudes and knowledge about dementia and related diagnoses. All studies used qualitative method. Data from different kind of RCTs was collected with questionnaires including open-ended questions, focus groups and individual interviews. Content analysis and Grounded theory were used.Study I Questionnaire with open-ended questions to 19 participants and 20 study partners in immunotherapy Alzheimer ́s disease (AD) phase I-II RCTs and group interview with eight staff members in the clinical trial unit were used. Staff members highlighted the high burden for the participants. The main motives for participation were a willingness to help research and the benefits of access to specialized care. The main disadvantages were that participating was time-consuming and perceived distress in connection to some investigations.Study II Focus group interviews were conducted within the Healthy Ageing Through Internet Counselling in the Elderly (HATICE) study with expert nurses (n=13) in cardiovascular disease (CVD) prevention in Finland and in the Netherlands. The purpose was to describe nurses' best experiences and practices with supporting CVD prevention and describe their suggestions on how to integrate their experiences into an online eHealth platform. Important aspects were to establish a relationship of trust, awareness and expectation management, and appropriate time and monitoring.Study III Focus groups interviews with older "at risk" adults (presence of CVD risk factors) in Finland, The Netherlands, and France were conducted as part of the HATICE study (n=44). The purpose was to explore attitudes of older adults at increased risk of CVD and dementia and engagement in an eHealth self-management prevention program as well as facilitators and barriers. The results were represented in three categories: access to reliable information about CVD and dementia, trust in the healthcare provider, and burden and stigma of dementia.Study IV Individual interviews with participants in multimodal dementia prevention MIND-ADMINI trial among persons with prodromal AD (n=8) were conducted. The participants' experience of participating in the trial is presented as a dynamic process. Previous knowledge, their motives, and the received information guide the participants' decision to take part in the trial. The trial was well tolerated and received even though the participants initially experienced high burden and difficulties managing information provided.Conclusions: Despite differences in the trials and target populations, the participants presented similar motives for participating in dementia prevention trials including altruistic, hope for personal benefits of the interventions, and access to specialized care. There are differences in the participants' preferences and need for support in a trial, between the participating countries, and along the disease continuum. To address this, a more person-centred approach in the conduction of the trials is suggested. This may improve participant ́s situation and the quality of RCTs which is important given the increasing complexity and new methods used in dementia prevention trials.
590 $a School code: 0658.
650 4 $a Gerontology. $3 533633
650 4 $a Epidemiology. $3 568544
650 4 $a Health care management. $3 2122906
653 $a COVID-19
653 $a Cognition
653 $a Biomarkers
653 $a Alzheimers disease
653 $a Reasoning
690 $a 0766
690 $a 0769
690 $a 0351
710 2 $a Karolinska Institutet (Sweden). $3 3557748
773 0 $t Dissertations Abstracts International $g 82-11B.
790 $a 0658
791 $a Ph.D.
792 $a 2021
793 $a English
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28518255